Antagonist activity at human GPR84 expressed in HEK293 cells co-expressing Galpha16 assessed as reduction in 6-OAU induced intracellular calcium response preincubated for 10 mins followed by agonist addition and measured after 1 min by calcium mobilization assay
Antagonist activity at human GPR84 expressed in HEK293 cells assessed as reversal of 6-OAU induced inhibition of forskolin induced intracellular cAMP production
Antagonist activity at mouse GPR84 expressed in HEK293 cells assessed as reduction in 6-OAU induced intracellular calcium response preincubated for 10 mins followed by agonist addition and measured after 1 min by calcium mobilization assay
Antagonist activity at GPR84 expressed in mouse bone marrow cells assessed as reduction in 6-OAU induced migration in neutrophils incubated for 90 mins by flow cytometry
Antagonist activity at GPR84 expressed in mouse bone marrow cells assessed as reduction in 6-OAU/3-OH-C12 induced migration in monocytes incubated for 90 mins by flow cytometry
Anti-colitis activity against DSS-induced ulcerative colitis mouse model assessed as attenuation of weight loss administered orally once daily for 7 consecutive days
Anti-colitis activity against DSS-induced ulcerative colitis mouse model assessed as attenuation of stool thinning administered orally once daily for 7 consecutive days